OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 02, 2018
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
With the right excipients, formulators can control when, where, and how an API is released.
June 25, 2018
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.
June 14, 2018
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
June 13, 2018
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
June 08, 2018
MilliporeSigma targets emerging biotechs with US development center and global grants.
June 01, 2018
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
Bosch Packaging Technology will introduce its newest R&D device for continuous oral solid dosage production at Achema 2018.
May 24, 2018
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.